Investors

Information for qualified investors.

GenengineAI is a pre-launch generative engine optimisation company, a subsidiary of X77 USA LLC. Accredited and eligible investors can request a company overview or, under a confidentiality agreement, the information memorandum.

This page is for information only. It is not an offer to sell or a solicitation of an offer to buy any security. Please read the important information at the foot of this page.

The market

A new category, already funded

Disclosed venture funding into AI visibility companies passed US$500 million within about a year, across more than 50 vendors.

Source: ThriveStack, July 2026.

The company

What we are building

A platform that tracks what AI assistants say about brands, companies and people, with a confidence range on every number, sold directly and through agencies.

Stage: pre-launch. The platform is in development.

Leadership

Led by AJ Smith

Technology entrepreneur and former chief executive and director of listed companies.

Read the founder profile

Request information

Two levels of information

Company overviewInformation memorandum
What it isA short summary of the company and productThe full confidential document
Confidentiality agreementNot neededSigned online, in about two minutes
Who can request itAny professional enquirerAccredited investors in the United States; eligible investors elsewhere
How you receive itBy emailBy email, after we review your request

How it works

  1. Tell us who you areYour details and your investor status.
  2. Sign the confidentiality agreementOnly for the information memorandum. You can read it first.
  3. We review and replyEvery request is reviewed by a person. Access is at our discretion.

Nothing on this website is the information memorandum. It is sent only on request.

Request information

What would you like?

A short summary. No confidentiality agreement needed.

Your investor status

We reply by email. We never share your details.

Important information

Please read

  • Not an offer. Nothing on this website is an offer to sell, or a solicitation of an offer to buy, any security in any jurisdiction. Any offer will be made only through definitive offering documents.
  • United States. Any securities will not be registered under the U.S. Securities Act of 1933 or any state securities law and will be offered only under an exemption from registration, such as Rule 506(c) of Regulation D, to investors who are accredited investors. We are required to take reasonable steps to verify accredited investor status before accepting any investment.
  • Outside the United States. Any offer will be made only to non-U.S. persons in transactions that comply with Regulation S and with the laws of the investor's own country. This website has not been reviewed or approved by any regulator in any country, including the Securities and Commodities Authority and the Dubai Financial Services Authority in the United Arab Emirates, and it is not a public offer of securities in any country.
  • No regulator has approved this. Neither the U.S. Securities and Exchange Commission nor any state securities authority has approved or disapproved any securities or passed on the accuracy of any information.
  • Risk. Investing in an early-stage private company is speculative and illiquid. Investors can lose their entire investment and may be unable to sell for a long time, or at all.
  • Forward-looking statements. Statements about plans, markets and expectations are forward-looking. They are not guarantees, and actual results may differ materially.
  • No advice. Nothing here is investment, legal or tax advice. Speak to your own advisers.
  • Third-party data. Market figures come from the sources named and have not been independently verified.

GenengineAI is a subsidiary of X77 USA LLC, a Wyoming limited liability company operating from Miami, Florida. Investor contact: sales@genengineai.com.

Get my free scan